Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer.
Publication/Presentation Date
5-2020
Volume
38
Issue
15
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Hematology-Medical Oncology Division
Document Type
Article
COinS